Foghorn Therapeutics Stock Price on December 13, 2024
| FHTX Stock | USD 5.51 0.21 3.96% |
Below is the normalized historical share price chart for Foghorn Therapeutics extending back to October 23, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Foghorn Therapeutics stands at 5.51, as last reported on the 18th of December 2024, with the highest price reaching 5.54 and the lowest price hitting 4.57 during the day.
If you're considering investing in Foghorn Stock, it is important to understand the factors that can impact its price. Foghorn Therapeutics secures Sharpe Ratio (or Efficiency) of -0.18, which denotes the company had a -0.18% return per unit of risk over the last 3 months. Foghorn Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Foghorn Therapeutics' Mean Deviation of 3.5, variance of 19.77, and Standard Deviation of 4.45 to check the risk estimate we provide.
Foghorn Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of October 2020 | 200 Day MA 6.8975 | 50 Day MA 7.7302 | Beta 3.148 |
Foghorn |
Sharpe Ratio = -0.179
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | FHTX |
Estimated Market Risk
| 4.42 actual daily | 39 61% of assets are more volatile |
Expected Return
| -0.79 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Foghorn Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Foghorn Therapeutics by adding Foghorn Therapeutics to a well-diversified portfolio.
Price Book 10.707 | Enterprise Value Ebitda (1.21) | Price Sales 12.0054 | Shares Float 26.1 M | Wall Street Target Price 14.5 |
Related Headline
C4 Therapeutics Headline on 13th of December 2024
Acquisition by Cooper Ronald Harold Wilfred of 65000 shares ... by Cooper Ronald Harold Wilfred
Filed transaction by C4 Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3
Foghorn Therapeutics Valuation on December 13, 2024
It is possible to determine the worth of Foghorn Therapeutics on a given historical date. On December 13, 2024 Foghorn was worth 5.74 at the beginning of the trading date compared to the closed value of 5.3. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Foghorn Therapeutics stock. Still, in general, we apply an absolute valuation method to find Foghorn Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Foghorn Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Foghorn Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 6.02 | 6.15 | 5.62 | 5.78 | 139,422 | |
12/13/2024 | 5.74 | 5.90 | 5.00 | 5.30 | 452,669 |
| 4.67 | 5.54 | 4.57 | 5.51 | 724,044 |
| Backtest Foghorn Therapeutics | | | Foghorn Therapeutics History | | | Foghorn Therapeutics Valuation | Previous | Next |
Foghorn Therapeutics Trading Date Momentum on December 13, 2024
| On December 16 2024 Foghorn Therapeutics was traded for 5.51 at the closing time. The top price for the day was 5.54 and the lowest listed price was 4.57 . The trading volume for the day was 724 K. The trading history from December 16, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 3.96% . The overall trading delta against the current closing price is 11.89% . |
Foghorn Therapeutics Fundamentals Correlations and Trends
By evaluating Foghorn Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Foghorn Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Foghorn financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Foghorn Therapeutics Stock history
Foghorn Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Foghorn is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Foghorn Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Foghorn Therapeutics stock prices may prove useful in developing a viable investing in Foghorn Therapeutics
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Foghorn Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 119 people.
Foghorn Therapeutics Stock Technical Analysis
Foghorn Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Foghorn Therapeutics Period Price Range
Low | December 18, 2024
| High |
0.00 | 0.00 |
Foghorn Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Foghorn Therapeutics December 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Foghorn Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Foghorn Therapeutics shares will generate the highest return on investment. By undertsting and applying Foghorn Therapeutics stock market strength indicators, traders can identify Foghorn Therapeutics entry and exit signals to maximize returns
Foghorn Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Foghorn Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Foghorn Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Foghorn to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.80) | |||
| Total Risk Alpha | (1.12) | |||
| Treynor Ratio | (1.54) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Foghorn Stock Analysis
When running Foghorn Therapeutics' price analysis, check to measure Foghorn Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn Therapeutics is operating at the current time. Most of Foghorn Therapeutics' value examination focuses on studying past and present price action to predict the probability of Foghorn Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn Therapeutics' price. Additionally, you may evaluate how the addition of Foghorn Therapeutics to your portfolios can decrease your overall portfolio volatility.